Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Sands Capital Life Sciences Pulse Fund II, L.P. reported a 5.30% stake in Acrivon Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Sands Capital Life Sciences Pulse Fund II, L.P. reported a 5.30% stake in Acrivon Therapeutics, Inc., 2,289,271 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
5.30%
Shares
2,289,271
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Sands Capital Life Sciences Pulse Fund II, L.P.5.30%2,289,271
Sands Capital Alternatives, LLC5.30%2,289,271
SANDS FRANK M.5.30%2,289,271

Source

View original at SEC

Related